医療レポート：Pediatric Respiratory Syncytial Virus Infection and Prophylactic Populations in the US-疫学予測（～2022）...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 3
1.1 List of Tables 5
1.2 List of Figures 5
2 Introduction 6
2.1 Catalyst 6
2.2 Upcoming Reports 7
3 Epidemiology 8
3.1 Risk Factors and Comorbidities 9
3.1.1 Re-hospitalization rate increases with lower gestational age 9
3.1.2 Congenital respiratory or neuromuscular diseases are more often re-hospitalized 9
3.1.3 Re-hospitalization is more frequent in chronic lung disease infants 10
3.1.4 More complications in children with hemodynamically significant congenital heart disease 10
3.1.5 Hospitalized cases likely to develop long-term respiratory problems 10
3.2 Trends in the US 11
3.2.1 RSV Infections and Hospitalization Rates 11
3.2.2 Preterm Births and Infant Mortality 11
3.2.3 Congenital Respiratory or Neuromuscular Diseases 11
3.2.4 Neonatal Chronic Lung Disease 12
3.2.5 Hemodynamically Significant Congenital Heart Diseases 12
3.3 Forecast Methodology 13
3.3.1 Sources Used 15
3.3.2 Forecast Assumptions and Methods (US) 17
3.3.3 Sources Not Used 22
3.4 Epidemiological Forecast of RSV Infections and Prophylactic Populations 23
3.4.1 Primary, Secondary, and Hospitalizations of RSV Infections 23
3.4.2 Preterm Population 25
3.4.3 Congenital Respiratory or Neuromuscular Diseases Population 29
3.4.4 Neonatal Chronic Lung Disease Population 30
3.4.5 Hemodynamically Significant Congenital Heart Diseases Population 31
3.4.6 RSV Infections and Prophylactic Populations Segmented by Sex 32
3.5 Discussion 34
3.5.1 Conclusions on Epidemiological Trends and Forecast 34
3.5.2 Limitations in Analysis 35
3.5.3 Strengths of Analysis 36
4 Appendix 37
4.1 Bibliography 37
4.2 About the Authors 41
4.2.1 Epidemiologists 41
4.2.2 Reviewers 41
4.2.3 Global Director of Epidemiology and Clinical Trials Analysis 43
4.2.4 Global Head of Healthcare 43
4.3 About GlobalData 44
4.4 About EpiCast 44
4.5 Contact Us 44
4.6 Disclaimer 45